Entera Bio Ltd. (NASDAQ:ENTX – Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 59,400 shares, a drop of 13.0% from the November 30th total of 68,300 shares. Approximately 0.3% of the company’s shares are sold short. […]
Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Entera Bio Ltd. (NASDAQ:ENTX – Get Free Report) CEO Miranda Jayne Toledano bought 23,952 shares of the stock in a transaction that occurred on Friday, December 22nd. The shares were bought at an average price of $0.71 per share, for a total transaction of $17,005.92. Following the completion of the transaction, the chief executive officer […]
Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera s Next Generation Oral Peptide Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
JERUSALEM, Nov. 14, 2023 (GLOBE NEWSWIRE) Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today